Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia

Author: Rishi Pukhraj  

Publisher: Springer Publishing Company

ISSN: 0721-832X

Source: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol.246, Iss.4, 2008-04, pp. : 619-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content